GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

BOKF · Jun 30, 2025

BOK FINANCIAL CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000875357-25-000045Bank
Sequential deposit growth30thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

-0.09% · CORE · VALID

Net-income growth30thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

-14.47% · CORE · VALID

Interest-income growth30thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

-4.37% · CORE · VALID

Cash and equivalents35thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$1.4B · CORE · VALID

Sequential loan growth85thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

2.58% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History30 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Decreased
Previous
0.24%
Current
-0.09%
Delta
-0.33%
Earnings Growth Decreased
Previous
43.10%
Current
-14.47%
Delta
-57.57%
Interest Income Growth Decreased
Previous
-4.13%
Current
-4.37%
Delta
-0.25%
Liquidity Decreased
Previous
$1.4B
Current
$1.4B
Delta
-$57.6M
Loan Growth Increased
Previous
-1.77%
Current
2.58%
Delta
4.35%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.